Exozymes Q3 2026 Results: Net Loss of $2.24M, Loss Narrows
EXOZYMES INC. reported a net loss of $7.49 million for the nine months ended September 30, 2026, compared to a $6.50 million loss in the prior year. The company remains in a development stage with no operating income, primarily funded by a public offering and registered direct offering that raised approximately $5.86 million in net proceeds during the period.
- Key figure
- Net loss $2.24M